An Open-label, Single-dose, Randomised, Crossover Study to Evaluate Changes in the Pharmacokinetics of Ibuprofen From Ibuprofen-LDH Dosed With and Without Release Modifying Excipients in Normal, Healthy, Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 08 May 2017
At a glance
- Drugs Ibuprofen (Primary) ; Ibuprofen lysinate
- Indications Musculoskeletal pain
- Focus Pharmacokinetics
- Sponsors Oxford Pharmascience
- 02 May 2017 Status changed from recruiting to completed.
- 14 Dec 2016 Status changed from not yet recruiting to recruiting.
- 29 Nov 2016 New trial record